Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant

Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile

van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708

Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)

McDonald, L. C., Gerding, D. N., Johnson, S., Bakken, J. S., Carroll, K. C., Coffin, S. E., Dubberke, E. R., Garey, K. W., Gould, C. V., Kelly, C., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix1085 · Cited by 2,690

European consensus conference on faecal microbiota transplantation in clinical practice

Cammarota, G., Ianiro, G., Tilg, H., Rajilić-Stojanović, M., Kump, P., Satokari, R., Sokol, H., Arkkila, P., Pintus, C., Hart, A., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-313017 · Cited by 1,207

Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)

McDonald, L. C., Gerding, D. N., Johnson, S., Bakken, J., Carroll, K. C., Coffin, S. E., Dubberke, E. R., Garey, K. W., Gould, C. V., Kelly, C. P., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy149 · Cited by 1,163

Antimicrobial Resistance and Virulence: a Successful or Deleterious Association in the Bacterial World?

Beceiro, A., Tomás, M., & Bou, G. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00059-12 · Cited by 1,118

Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis

Kassam, Z., Lee, C. H., Yuan, Y., & Hunt, R. H. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.59 · Cited by 904

Pathological bacterial translocation in liver cirrhosis

Wiest, R., Lawson, M. A., & Geuking, M. B. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.07.044 · Cited by 826

Oral, Capsulized, Frozen Fecal Microbiota Transplantation for Relapsing Clostridium difficile Infection

Youngster, I., Russell, G. H., Pindar, C., Ziv-Baran, T., Sauk, J., & Hohmann, E. L. (2014) · JAMA · doi:10.1001/jama.2014.13875 · Cited by 629

Whole genome sequencing options for bacterial strain typing and epidemiologic analysis based on single nucleotide polymorphism versus gene-by-gene–based approaches

Schürch, A. C., Arredondo-Alonso, S., Willems, R. J. L., & Goering, R. V. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.12.016 · Cited by 534

The use of faecal microbiota transplant as treatment for recurrent or refractoryClostridium difficileinfection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines

Mullish, B. H., Quraishi, M. N., Segal, J. P., McCune, V. L., Baxter, M., Marsden, G. L., Moore, D., Colville, A., Bhala, N. B., Iqbal, T. H., et al. (2018) · Gut · doi:10.1136/gutjnl-2018-316818 · Cited by 344

Fecal microbiota transplantation for irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials

Wang, M., Xie, X., Zhao, S., Ma, X., Wang, Z., & Zhang, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1136343 · Cited by 27

Biomimetic superabsorbent hydrogel acts as a gut protective dynamic exoskeleton improving metabolic parameters and expanding A. muciniphila

Silvestri, A., Gil‐Gómez, A., Vitale, M., Braga, D., Demitri, C., Brescia, P., Madaghiele, M., Spadoni, I., Jones, B., Fornasa, G., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101235 · Cited by 28

Faecal microbial transplantation in IBS: ready for prime time?

Barbara, G., & Ianiro, G. (2020) · Gut · doi:10.1136/gutjnl-2019-320411 · Cited by 27

Systematic Review with Meta-Analysis: Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides difficile

Tixier, E. N., Verheyen, E., Luo, Y., Grinspan, L. T., Du, C., Ungaro, R. C., Walsh, S., & Grinspan, A. M. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-06908-4 · Cited by 27

Clostridioides difficile pathogenesis and control

Chilton, C. H., Viprey, V. F., Normington, C., Moura, I. B., Buckley, A. M., Freeman, J., Davies, K., & Wilcox, M. H. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-025-01242-2 · Cited by 26

Results from the first English stool bank using faecal microbiota transplant as a medicinal product for the treatment of Clostridioides difficile infection

McCune, V. L., Quraishi, M. N., Manzoor, S. E., Moran, C. E., Banavathi, K., Steed, H., Massey, D. C. O., Trafford, G., Iqbal, T. H., & Hawkey, P. M. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100301 · Cited by 26

Microbiome-based interventions: therapeutic strategies in cancer immunotherapy

Chervin, C. S., & Gajewski, T. F. (2020) · Immuno-Oncology Technology · doi:10.1016/j.iotech.2020.11.001 · Cited by 26

The role of faecal microbiota transplantation: looking beyond Clostridioides difficile infection

Goldenberg, S. D., & Merrick, B. (2021) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936120981526 · Cited by 28

Clinical Application and Progress of Fecal Microbiota Transplantation in Liver Diseases: A Review

Gu, X., Lu, Q., Zhang, C., Tang, Z., & Chu, L. (2021) · Seminars in Liver Disease · doi:10.1055/s-0041-1732319 · Cited by 26

Phage therapy for Clostridioides difficile infection

Fujimoto, K., & Uematsu, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1057892 · Cited by 26

Recommendations for the diagnosis and treatment of Clostridioides difficile infection: An official clinical practice guideline of the Spanish Society of Chemotherapy (SEQ), Spaish Society of Internal Medicine (SEMI) and the working group of Postoperative Infection of the Spanish Society of Anesthesia and Reanimation (SEDAR)

Infecciosas, I. D. I. S. G. M. S. D. M. C. Y. E., Bouza, E., Aguado, J. M., Alcalá, L., Almirante, B., Alonso‐Fernández, P., Borges-Sa, M., Cobo, J., Guardiola, J., Horcajada, J. P., et al. (2020) · Revista Española de Quimioterapia · doi:10.37201/req/2065.2020 · Cited by 26

Host–microbe cross-talk in the lung microenvironment: implications for understanding and treating chronic lung disease

Gosens, R., Hiemstra, P. S., Adcock, I. M., Bracke, K. R., Dickson, R. P., Hansbro, P. M., Krauss‐Etschmann, S., Smits, H. H., Stassen, F. R. M., & Bartel, S. (2020) · European Respiratory Journal · doi:10.1183/13993003.02320-2019 · Cited by 28

The Changes in the p53 Protein across the Animal Kingdom Point to Its Involvement in Longevity

Bartas, M., Brázda, V., Volná, A., Červeň, J., Pečínka, P., & Zawacka‐Pankau, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168512 · Cited by 29

First Case of Covid-19 in the United States

Weng, L., Jiao, Y., & Li, Y. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2004794 · Cited by 26

The Gut Microbiota in Kidney Transplantation: A Target for Personalized Therapy?

Martínez, Y. G., Borriello, M., Capolongo, G., Ingrosso, D., & Perna, A. F. (2023) · Biology · doi:10.3390/biology12020163 · Cited by 25

Harnessing the human gut microbiota: an emerging frontier in combatting multidrug-resistant bacteria

Ding, W., Cheng, Y., Liu, X., Zhu, Z., Wu, L., Gao, J., Lei, W., Li, Y., Zhou, X., Wu, J., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1563450 · Cited by 26

Novel Insights Into Pathogenesis and Therapeutic Strategies of Hepatic Encephalopathy, From the Gut Microbiota Perspective

Liu, J., Xu, Y., & Jiang, B. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.586427 · Cited by 25

Clearance of Clostridioides difficile Colonization Is Associated with Antibiotic-Specific Bacterial Changes

Lesniak, N. A., Schubert, A. M., Sinani, H., & Schloss, P. D. (2021) · mSphere · doi:10.1128/msphere.01238-20 · Cited by 26

Sepsis-Induced Myopathy and Gut Microbiome Dysbiosis: Mechanistic Links and Therapeutic Targets

Mankowski, R. T., Laitano, O., Darden, D. B., Kelly, L. S., Munley, J. A., Loftus, T. J., Mohr, A. M., Efron, P. A., & Thomas, R. M. (2021) · Shock · doi:10.1097/shk.0000000000001843 · Cited by 25

Using the microbiome in clinical practice

Turjeman, S., & Koren, O. (2021) · Microbial Biotechnology · doi:10.1111/1751-7915.13971 · Cited by 25

The role of faecal microbiota transplantation in chronic noncommunicable disorders

Mullish, B. H., Tohumcu, E., Porcari, S., Fiorani, M., Tommaso, N. D., Gasbarrini, A., Cammarota, G., Ponziani, F. R., & Ianiro, G. (2023) · Journal of Autoimmunity · doi:10.1016/j.jaut.2023.103034 · Cited by 25

Long-Term Safety Outcomes of Fecal Microbiota Transplantation: Real-World Data Over 8 Years From the Hong Kong FMT Registry

Yau, Y. K., Lau, L. H. S., Lui, R. N. S., Wong, S. H., Guo, C. L., Mak, J. W. Y., Ching, J. Y. L., Ip, M., Kamm, M. A., Rubin, D. T., et al. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.09.001 · Cited by 25

Modulation of gut microbiota: a novel approach to enhancing the effects of immune checkpoint inhibitors

Huang, J., Gong, C., & Zhou, A. (2023) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359231204854 · Cited by 30

My Treatment Approach to Clostridioides difficile Infection

Khanna, S. (2021) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2021.03.033 · Cited by 25

Microbiota-Based Live Biotherapeutic Products for Clostridioides Difficile Infection- The Devil is in the Details

Monday, L., Tillotson, G., & Chopra, T. (2024) · Infection and Drug Resistance · doi:10.2147/idr.s419243 · Cited by 24

Safety and Tolerability of CP101, a Full-Spectrum, Oral Microbiome Therapeutic for the Prevention of Recurrent Clostridioides difficile Infection: A Phase 2 Randomized Controlled Trial

Allegretti, J. R., Kelly, C. R., Louie, T., Fischer, M., Hota, S. S., Misra, B. K., van Hise, N., Yen, E. F., Bullock, J., Silverman, M., et al. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.09.030 · Cited by 24

Fecal Microbiota Transplantation in Children with Autism

Li, Y., Xiao, P. G., Ding, H., Wang, H., Xu, Q., Wang, R., Zheng, L., Song, X., Wang, Y., & Zhang, T. (2024) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s488001 · Cited by 24

Gut microbiota as a hidden modulator of chemotherapy: implications for colorectal cancer treatment

Sadeghloo, Z., & Sadeghi, A. (2025) · Discover Oncology · doi:10.1007/s12672-025-03574-0 · Cited by 24

Microbiota-based approaches to mitigate infectious complications of intensive chemotherapy in patients with acute leukemia

Rashidi, A., & Weisdorf, D. J. (2020) · Translational research · doi:10.1016/j.trsl.2020.03.011 · Cited by 24

Ten-Year Follow-Up of Patients Treated with Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection from a Randomized Controlled Trial and Review of the Literature

Ooijevaar, R. E., van Nood, E., Goorhuis, A., Terveer, E. M., van Prehn, J., Verspaget, H. W., van Beurden, Y. H., Dijkgraaf, M. G. W., & Keller, J. J. (2021) · Microorganisms · doi:10.3390/microorganisms9030548 · Cited by 24

Tandem fecal microbiota transplantation cycles in an allogeneic hematopoietic stem cell transplant recipient targeting carbapenem-resistant Enterobacteriaceae colonization: a case report and literature review

Su, F., Luo, Y., Yu, J., Shi, J., Zhao, Y., Yan, M., Huang, H., & Tan, Y. (2021) · European journal of medical research · doi:10.1186/s40001-021-00508-8 · Cited by 24

The Role of Gut Dysbiosis in Acute-on-Chronic Liver Failure

Kim, S. E., Park, J. W., Kim, H. S., Jang, M. K., Suk, K. T., & Kim, D. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111680 · Cited by 24

Targeting the gut microbiome in the management of sepsis-associated encephalopathy

Barlow, B., Ponnaluri, S., Barlow, A., & Roth, W. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.999035 · Cited by 25

Vascular traffic control of neutrophil recruitment to the liver by microbiota-endothelium crosstalk

Zucoloto, A. Z., Schlechte, J., Ignácio, A., Thomson, C. A., Pyke, S., Yu, I.-L., Geuking, M. B., McCoy, K. D., Yipp, B. G., Gillrie, M. R., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112507 · Cited by 24

Microbial Players in Primary Sclerosing Cholangitis: Current Evidence and Concepts

Özdirik, B., & Schnabl, B. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.12.005 · Cited by 25

Recurrent Clostridioides difficile Infection: Current Clinical Management and Microbiome-Based Therapies

Berry, P., & Khanna, S. (2023) · BioDrugs · doi:10.1007/s40259-023-00617-2 · Cited by 23

Fecal Microbiota Transplantation: Indications, Methods, and Challenges

Lee, J. Y., Kim, Y., Kim, J., & Kim, J. K. (2024) · The Journal of Microbiology · doi:10.1007/s12275-024-00184-3 · Cited by 23

Fecal microbiota transplantation: Current evidence and future directions

Cymbal, M., Chatterjee, A., & Baggott, B. B. (2025) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.92a.24107 · Cited by 23

Next Generation Fecal Microbiota Transplantation

Gweon, T., & Na, S. (2021) · Clinical Endoscopy · doi:10.5946/ce.2021.053 · Cited by 23

A seed-like hydrogel with metabolic cascade microbiota for oral treatment of liver failure

Zheng, D., Chen, K.-W., Yan, J., Rao, Z., Yang, C.-H., Li, R., Tang, Y., Cheng, H. L., & Zhang, X. (2022) · Materials Today · doi:10.1016/j.mattod.2022.07.014 · Cited by 23

Targeted modulation of gut and intra-tumor microbiota to improve the quality of immune checkpoint inhibitor responses

Wang, W., Fan, J., Zhang, C., Huang, Y., Chen, Y., Fu, S., & Wu, J. (2024) · Microbiological Research · doi:10.1016/j.micres.2024.127668 · Cited by 25

Recent advances in understanding and managing hepatic encephalopathy in chronic liver disease

Kerbert, A. J. C., & Jalan, R. (2020) · F1000Research · doi:10.12688/f1000research.22183.1 · Cited by 23

Optimising management strategies of inflammatory bowel disease in resource-limited settings in Asia

Ng, S. C., Mak, J. W. Y., Pal, P., & Banerjee, R. (2020) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(20)30298-3 · Cited by 23

The Interplay between Gut Microbiota and the Immune System in Liver Transplant Recipients and Its Role in Infections

Ancona, G., Alagna, L., Lombardi, A., Palomba, E., Castelli, V., Renisi, G., Dondossola, D. E., Iavarone, M. A., Muscatello, A., Gori, A., et al. (2021) · Infection and Immunity · doi:10.1128/iai.00376-21 · Cited by 23

Causal role of the gut microbiome in certain human diseases: a narrative review

Prosty, C. J., Katergi, K., Papenburg, J., Lawandi, A., Lee, T. C., Shi, H., Burnham, P., Swem, L. R., Routy, B., Yansouni, C. P., et al. (2024) · eGastroenterology · doi:10.1136/egastro-2024-100086 · Cited by 22

End-to-end donor screening and manufacturing controls: complementary quality-based strategies to minimize patient risk for donor-derived microbiome therapeutics

Goldsmith, J. R., Tomkovich, S., Aunins, J. G., McGovern, B., Mahoney, J. C., Hasson, B. R., McChalicher, C. W. J., & Ege, D. S. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2402550 · Cited by 22

The microbiome in pediatric oncology

Rotz, S. J., & Dandoy, C. E. (2020) · Cancer · doi:10.1002/cncr.33030 · Cited by 22

Origins of bloodstream infections following fecal microbiota transplantation: a strain-level analysis

Eshel, A., Sharon, I., Nagler, A., Bomze, D., Danylesko, I., Fein, J. A., Geva, M., Henig, I. J., Shimoni, A., Zuckerman, T., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021005110 · Cited by 22

The Host CYP1A1-Microbiota Metabolic Axis Promotes Gut Barrier Disruption in Methicillin-Resistant Staphylococcus aureus-Induced Abdominal Sepsis

Ma, X., Jin, H., Chu, X., Dai, W., Tang, W., Zhu, J., Wang, F., Yang, X., Li, W., Liu, G., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.802409 · Cited by 22

The Impact of Human Microbiotas in Hematopoietic Stem Cell and Organ Transplantation

Sen, T., & Thummer, R. P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.932228 · Cited by 22

The long and sinuous road to phage-based therapy of Clostridioides difficile infections

Umansky, A. A., & Fortier, L. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1259427 · Cited by 23

The gut microbiome: an important role in neurodegenerative diseases and their therapeutic advances

Li, S., Zhao, L., Xiao, J., Guo, Y., Fu, R., Zhang, Y., & Xu, S. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04853-6 · Cited by 23

Clostridioides difficile infections; new treatments and future perspectives

Normington, C., Chilton, C. H., & Buckley, A. M. (2023) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000989 · Cited by 22

Control points for design of taxonomic composition in synthetic human gut communities

Connors, B., Thompson, J. C., Sarah, E., Clark, R. L., Pfleger, B. F., & Venturelli, O. S. (2023) · Cell Systems · doi:10.1016/j.cels.2023.11.007 · Cited by 22

Bacteria-based drug delivery for treating non-oncological diseases

Cao, Z., Pang, Y., Pu, J., & Liu, J. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.01.020 · Cited by 22

Balancing the risks and rewards of live biotherapeutics

Hill, C. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0254-3 · Cited by 22

American Society of Transplantation and Cellular Therapy Series, 1: Enterobacterales Infection Prevention and Management after Hematopoietic Cell Transplantation

Satlin, M. J., Weissman, S. J., Carpenter, P. A., Seo, S. K., & Shelburne, S. A. (2021) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2020.10.001 · Cited by 21

Crosstalk Between Intestinal Microbiota Derived Metabolites and Tissues in Allogeneic Hematopoietic Cell Transplantation

Fujiwara, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.703298 · Cited by 22

Frontiers in antibiotic alternatives for Clostridioides difficile infection

Phanchana, M., Harnvoravongchai, P., Wongkuna, S., Phetruen, T., Phothichaisri, W., Panturat, S., Pipatthana, M., Charoensutthivarakul, S., Chankhamhaengdecha, S., & Janvilisri, T. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i42.7210 · Cited by 23

Antibiotic use and ileocolonic immune cells in patients receiving fecal microbiota transplantation for refractory intestinal GvHD: a prospective cohort study

Spindelboeck, W., Halwachs, B., Bayer, N., Huber-Kraßnitzer, B., Schulz, E., Uhl, B., Gaksch, L., Hatzl, S., Bachmayr, V., Kleißl, L., et al. (2021) · Therapeutic Advances in Hematology · doi:10.1177/20406207211058333 · Cited by 21

Fecal Microbiota Transplant for Hematologic and Oncologic Diseases: Principle and Practice

Zerdan, M. B., Niforatos, S., Nasr, S., Nasr, D., Ombada, M., John, S., Dutta, D., & Lim, S. H. (2022) · Cancers · doi:10.3390/cancers14030691 · Cited by 22

American Society for Transplantation and Cellular Therapy Series: #5—Management of Clostridioides difficile Infection in Hematopoietic Cell Transplant Recipients

Alonso, C. D., Marón, G. M., Kamboj, M., Carpenter, P. A., Gurunathan, A., Mullane, K. M., & Dubberke, E. R. (2022) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2022.02.013 · Cited by 21

Drugging the microbiome and bacterial live biotherapeutic consortium production

McChalicher, C. W. J., & Aunins, J. G. (2022) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2022.102801 · Cited by 22

Microecological regulation in HCC therapy: Gut microbiome enhances ICI treatment

Liu, X., Li, S., Wang, L., & Ma, K. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167230 · Cited by 21

Fecal Microbiota Transplantation for Clostridioides Difficile Infection in Patients with Chronic Liver Disease

Meighani, A., Alimirah, M., Ramesh, M. S., & Salgia, R. J. (2020) · International Journal of Hepatology · doi:10.1155/2020/1874570 · Cited by 21

The gut microbiome: what every gastroenterologist needs to know

Mullish, B. H., Quraishi, M. N., Segal, J. P., Ianiro, G., & Iqbal, T. H. (2020) · Frontline Gastroenterology · doi:10.1136/flgastro-2019-101376 · Cited by 21

Impact of microbiome-based interventions on gastrointestinal pathogen colonization in the intensive care unit

Choy, A. M., & Freedberg, D. E. (2020) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284820939447 · Cited by 22

The role of microbiota in allogeneic hematopoietic stem cell transplantation

Chang, C.-C., Hayase, E., & Jenq, R. R. (2021) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2021.1872541 · Cited by 20

Host-microbe interactions and outcomes in multiple myeloma and hematopoietic stem cell transplantation

Pianko, M. J., & Golob, J. L. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10033-7 · Cited by 20

Multi-omic Profiling Reveals that Intra-abdominal-Hypertension-Induced Intestinal Damage Can Be Prevented by Microbiome and Metabolic Modulations with 5-Hydroxyindoleacetic Acid as a Diagnostic Marker

Li, F., Jiang, L., Pan, S., Jiang, S., Fan, Y., Jiang, C., Gao, C., & Leng, Y. (2022) · mSystems · doi:10.1128/msystems.01204-21 · Cited by 21

Manufacturing Process of SER-109, a Purified Investigational Microbiome Therapeutic, Reduces Risk of Coronavirus Transmission From Donor Stool

McChalicher, C. W. J., Abdulaziz, A., Zhou, S. S., Lombardo, M.-J., Hasson, B. R., Aunins, J. G., McGovern, B., & Ege, D. S. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac448 · Cited by 20

A case report of improvement on ADHD symptoms after fecal microbiota transplantation with gut microbiome profiling pre- and post-procedure

Hooi, S. L., Dwiyanto, J., Rasiti, H., Toh, K. Y., Wong, R. K. M., & Lee, J. W. J. (2022) · Current Medical Research and Opinion · doi:10.1080/03007995.2022.2129232 · Cited by 20

The Role of the Gut Microbiome in Pediatric Obesity and Bariatric Surgery

Akagbosu, C., Nadler, E. P., Levy, S., & Hourigan, S. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315421 · Cited by 22

Fecal microbiota transplantation attenuates Escherichia coli infected outgrowth by modulating the intestinal microbiome

Wang, Y., He, Y., Liang, Y., Liu, H., Chen, X., Kulyar, M. F., Shahzad, A., Wei, K., & Li, K. (2023) · Microbial Cell Factories · doi:10.1186/s12934-023-02027-z · Cited by 20

The human microbiome and gut–liver axis in people living with HIV

Duarte, M., Tien, P. C., Somsouk, M., & Price, J. C. (2023) · Current HIV/AIDS Reports · doi:10.1007/s11904-023-00657-x · Cited by 20

Effects of fecal microbiota transplantation and fecal virome transplantation on LPS-induced intestinal injury in broilers

Wu, D., Liang, S., Du, X., Xiao, J., Feng, H., Ren, Z., Yang, X., & Yang, X. (2023) · Poultry Science · doi:10.1016/j.psj.2023.103316 · Cited by 20

The gastrointestinal tract and Parkinson’s disease

Higinbotham, A. S., & Kilbane, C. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1158986 · Cited by 22

Current perspectives on fecal microbiota transplantation in inflammatory bowel disease

Singh, A., Midha, V., Chauhan, N. S., & Sood, A. (2024) · Indian Journal of Gastroenterology · doi:10.1007/s12664-023-01516-8 · Cited by 20

Fecal Microbiota Transplantation for Ulcerative Colitis: An Evolving Therapy

Sood, A., Singh, A., Midha, V., Mahajan, R., Kao, D. H., Rubin, D. T., & Bernstein, C. N. (2020) · Crohn s & Colitis 360 · doi:10.1093/crocol/otaa067 · Cited by 21

Predictors of steroid non-response and new approaches in severe alcoholic hepatitis

Sarin, S. K., & Sharma, S. (2020) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0196 · Cited by 20

A Triple Threat? The Role of Diet, Nutrition, and the Microbiota in T1D Pathogenesis

Hamilton‐Williams, E. E., Lorca, G. L., Norris, J. M., & Dunne, J. L. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.600756 · Cited by 20

Donor program for fecal microbiota transplantation: A 3-year experience of a large-volume Italian stool bank

Ianiro, G., Porcari, S., Bibbò, S., Giambò, F., Quaranta, G., Masucci, L., Sanguinetti, M., Gasbarrini, A., & Cammarota, G. (2021) · Digestive and Liver Disease · doi:10.1016/j.dld.2021.04.009 · Cited by 19

The Gut Microbiome and Its Multifaceted Role in Cancer Metabolism, Initiation, and Progression: Insights and Therapeutic Implications

Xu, K., Motiwala, Z. Y., Corona‐Avila, I., Makhanasa, D., Alkahalifeh, L., & Khan, M. W. (2025) · Technology in Cancer Research & Treatment · doi:10.1177/15330338251331960 · Cited by 22

The Gut Microbiome as a Biomarker and Therapeutic Target of Immune Checkpoint Inhibitors: A Review for Oncologists

Susiriwatananont, T., Eiamprapaporn, P., Roque, M. V., Farraye, F. A., Pearlman, A., & Chumsri, S. (2025) · Cells · doi:10.3390/cells14221779 · Cited by 19

Fecal microbiota transplantation for treatment of patients with recurrent Clostridioides difficile infection

Voth, E. R., & Khanna, S. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1752192 · Cited by 19

Intervention strategies for microbial therapeutics in cancer immunotherapy

Gopalakrishnan, V., Weiner, B. J., Ford, C. B., Sellman, B. R., Hammond, S. A., Freeman, D. J., Dennis, P. A., Soria, J., Wortman, J. R., & Henn, M. R. (2020) · Immuno-Oncology Technology · doi:10.1016/j.iotech.2020.05.001 · Cited by 20

Fecal Microbiota Transplantation Is Safe for Clostridiodies difficile Infection in Patients with Solid Tumors Undergoing Chemotherapy

Mendelsohn, R. B., Kaltsas, A., King, S. J., Hwang, C., Kassam, Z., Abend, A. M., Kramer, E., & Kamboj, M. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-07024-z · Cited by 19

Gut Microbiota Interventions for the Management of Obesity: A Literature Review

Gill, V. J. S., Soni, S., Shringarpure, M., ., A., Bhardwaj, S., Yadav, N. K., Patel, A., & Patel, A. (2022) · Cureus · doi:10.7759/cureus.29317 · Cited by 19

Fecal Microbiota Transplantation as a Cancer Therapeutic

Stoff, R., Wolf, Y., & Boursi, B. (2023) · The Cancer Journal · doi:10.1097/ppo.0000000000000651 · Cited by 20

Returning to Nature for the Next Generation of Antimicrobial Therapeutics

MacNair, C. R., Tsai, C. N., Rutherford, S. T., & Tan, M. (2023) · Antibiotics · doi:10.3390/antibiotics12081267 · Cited by 20

Efficacy and Safety of Fecal Transplantation Versus Targeted Therapies in Ulcerative Colitis: Network Meta-Analysis

Vuyyuru, S. K., Kedia, S., Kalaivani, M., Sahu, P., Kante, B., Kumar, P., Ranjan, M. K., Makharia, G. K., Ananthakrishnan, A. N., & Ahuja, V. (2021) · Future Microbiology · doi:10.2217/fmb-2020-0242 · Cited by 19

Microbiota, IgA and Multiple Sclerosis

Boussamet, L., Rajoka, M. S. R., & Berthelot, L. (2022) · Microorganisms · doi:10.3390/microorganisms10030617 · Cited by 20

Shaping the future of probiotics, live biotherapeutic products, and fecal microbiota transplantation: 30 scientific recommendations from the CHINAGUT Conference

Wang, W., Bu, N., Cao, H., Chen, N., Chen, W., Cheng, L., Cui, B., Dai, L., Gao, H., Guo, M., et al. (2025) · iMeta · doi:10.1002/imt2.70083 · Cited by 19

The role of intestinal flora in metabolic dysfunction-associated steatotic liver disease and treatment strategies

Wang, L. J., Sun, J., Chen, S., Sun, Y., Zheng, Y., & Feng, J. C. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2024.1490929 · Cited by 19

Gut Microbiota Metabolites Targeting the Immune Response in Sepsis: Mechanisms and Therapies

Xu, P. (2025) · International Journal of General Medicine · doi:10.2147/ijgm.s539237 · Cited by 18

Hot topics on fecal microbiota transplantation for the treatment of inflammatory bowel disease

Zhang, X., Ishikawa, D., Ohkusa, T., Fukuda, S., & Nagahara, A. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1068567 · Cited by 18

Microbiota‐related metabolites fueling the understanding of ischemic heart disease

Fan, Y., Ying, J., Ma, H., & Cui, H. (2023) · iMeta · doi:10.1002/imt2.94 · Cited by 18

Donor screening for fecal microbiota transplantation with a direct stool testing-based strategy: a prospective cohort study

Rondinella, D., Quaranta, G., Rozera, T., D’Argenio, P., Fancello, G., Venturini, I., Guarnaccia, A., Porcari, S., Bibbò, S., Sanguinetti, M., et al. (2024) · Microbes and Infection · doi:10.1016/j.micinf.2024.105341 · Cited by 18

Clinical and economic impact of bacterial resistance: an approach to infection control and antimicrobial stewardship solutions

Calbo, E., Boix-Palop, L., & Garau, J. (2020) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000694 · Cited by 18

Microbiota restoration for recurrent Clostridioides difficile: Getting one step closer every day!

Khanna, S. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13290 · Cited by 18

Drug-Resistant Bacteremia after Fecal Microbiota Transplant

Bleibtreu, A., Kapel, N., & Galpérine, T. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2002496 · Cited by 28

High carriage rate of extended‐spectrum β‐lactamase Enterobacterales and diarrheagenic Escherichia coli in healthy donor screening for fecal microbiota transplantation

Chuang, C., Lee, K., Wang, Y., Lee, P., Chang, T.-E., Huang, Y., Lin, Y.-T., & Hou, M. (2023) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-023-04644-3 · Cited by 16

Origins of bloodstream infections following fecal microbiota transplantation: a strain-level analysis

Eshel, A., Sharon, I., Nagler, A., Bomze, D., Danylesko, I., Fein, J. A., Geva, M., Henig, I. J., Shimoni, A., Zuckerman, T., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021005110 · Cited by 22

427 – Fecal Microbiota Transplantation Regulates Circulating Microrna Expression Levels in Patients with Recurrent Clostridioides Infection

Monaghan, T. M., Pomenya, O., Yau, T. O., Christodoulou, N., Hatziapostolou, M., Jilani, T. A., Kao, D. H., & Polytarchou, C. (2019) · Gastroenterology · doi:10.1016/s0016-5085(19)37000-3

Improving Risk–Benefit in Faecal Transplantation through Microbiome Screening

Papanicolas, L. E., Gordon, D., Wesselingh, S. L., & Rogers, G. B. (2020) · Trends in Microbiology · doi:10.1016/j.tim.2019.12.009 · Cited by 47